![Practice Parameter for the Use of Stimulant Medications in the Treatment of Children, Adolescents, and Adults - Journal of the American Academy of Child & Adolescent Psychiatry Practice Parameter for the Use of Stimulant Medications in the Treatment of Children, Adolescents, and Adults - Journal of the American Academy of Child & Adolescent Psychiatry](https://www.jaacap.org/cms/attachment/080e4784-a1c5-4667-9d8b-f66f60a01e25/gr1_lrg.gif)
Practice Parameter for the Use of Stimulant Medications in the Treatment of Children, Adolescents, and Adults - Journal of the American Academy of Child & Adolescent Psychiatry
![Review of ADHD Pharmacotherapies: Advantages, Disadvantages, and Clinical Pearls - Journal of the American Academy of Child & Adolescent Psychiatry Review of ADHD Pharmacotherapies: Advantages, Disadvantages, and Clinical Pearls - Journal of the American Academy of Child & Adolescent Psychiatry](https://www.jaacap.org/cms/attachment/e7b686f6-b66c-4a5a-a91a-a2d198bce4f8/gr1.gif)
Review of ADHD Pharmacotherapies: Advantages, Disadvantages, and Clinical Pearls - Journal of the American Academy of Child & Adolescent Psychiatry
![Western Medical Research conference (formerly Western Regional Meeting), January 25–27 2018, Carmel, California | JIM Western Medical Research conference (formerly Western Regional Meeting), January 25–27 2018, Carmel, California | JIM](https://d3hme472k3gd2d.cloudfront.net/content/jim/66/1/63/F8.large.jpg)
Western Medical Research conference (formerly Western Regional Meeting), January 25–27 2018, Carmel, California | JIM
![A Post Hoc Comparison of Prior ADHD Medication Dose and Optimized Delayed-release and Extended-release Methylphenidate Dose in a Pivotal Phase III Trial - ScienceDirect A Post Hoc Comparison of Prior ADHD Medication Dose and Optimized Delayed-release and Extended-release Methylphenidate Dose in a Pivotal Phase III Trial - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0149291820304719-gr1.jpg)